Biotech stocks rebounded in last week after declining modestly in the previous week. Some of the drugs that cleared the FDA hurdle this week include Ardelyx Inc (NASDAQ: ARDX )’s constipation drug Ibsrela; …

source https://finance.yahoo.com/news/week-ahead-biotech-novo-nordisk-151811689.html?.tsrc=rss